Report error Found 27 Enz. Inhib. hit(s) with all data for entry = 50027313
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 3nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 6nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 12nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 20nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 27nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 30nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 34nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 36nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 41nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 45nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 46nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 47nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 48nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 53nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 69nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 81nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 110nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 170nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.20E+3nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetTyrosine-protein kinase ITK/TSK(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.00E+4nMAssay Description:Inhibition of ITK by DELPHIA assayMore data for this Ligand-Target Pair
TargetCytochrome P450 1A2(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of CYP1A2More data for this Ligand-Target Pair
TargetCytochrome P450 2C9(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of CYP2C9More data for this Ligand-Target Pair
TargetCytochrome P450 2C19(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of CYP2C19More data for this Ligand-Target Pair
TargetCytochrome P450 2D6(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of CYP2D6More data for this Ligand-Target Pair
TargetCytochrome P450 3A4(Human)
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Johnson & Johnson Pharmaceutical Research and Development
Curated by ChEMBL
Affinity DataIC50: 1.40E+4nMAssay Description:Inhibition of CYP3A4More data for this Ligand-Target Pair
